Perindopril and candesartan comparative efficacy and safety in type II diabetic hypertensive patients.
作者信息
Derosa G, Cicero A F G, Mugellini A, Ciccarelli L, Fogari R
出版信息
J Hum Hypertens. 2003 Jun;17(6):433-5. doi: 10.1038/sj.jhh.1001572.
PMID:12764407
Abstract
摘要
相似文献
1
Perindopril and candesartan comparative efficacy and safety in type II diabetic hypertensive patients.
J Hum Hypertens. 2003 Jun;17(6):433-5. doi: 10.1038/sj.jhh.1001572.
2
A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus.
Clin Ther. 2003 Jul;25(7):2006-21. doi: 10.1016/s0149-2918(03)80201-1.
3
Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
J Stroke Cerebrovasc Dis. 2010 Nov-Dec;19(6):435-40. doi: 10.1016/j.jstrokecerebrovasdis.2009.08.006. Epub 2010 Aug 11.
4
Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial.
J Hum Hypertens. 2005 Jun;19(6):429-37. doi: 10.1038/sj.jhh.1001812.
5
Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex).
Hypertens Res. 2011 Dec;34(12):1295-301. doi: 10.1038/hr.2011.120. Epub 2011 Aug 11.
6
Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice.
Diabetes Res Clin Pract. 2007 Sep;77(3):492-3. doi: 10.1016/j.diabres.2007.01.008. Epub 2007 Feb 16.
7
Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial.
Hypertens Res. 2010 Jun;33(6):600-6. doi: 10.1038/hr.2010.38. Epub 2010 Apr 9.
8
Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies.
Heart. 2011 Mar;97(6):479-84. doi: 10.1136/hrt.2009.192104. Epub 2011 Feb 4.
9
Autoregulated glomerular filtration rate during candesartan treatment in hypertensive type 2 diabetic patients.
Curr Hypertens Rep. 2002 Dec;4(6):437-8. doi: 10.1007/s11906-002-0022-5.
10
[Hypotensive and metabolic effect of indapamide and perindopril in patients with type 2 diabetes and arterial hypertensia].
Georgian Med News. 2009 Apr(169):44-8.
Zotero 插件